Clinical Trial Update: A Study to Compare Severe Asthma Patients Who Start Biologics and Who do Not Start (PROSPECT)

View source ↗

Summary

A clinical trial update describing PROSPECT, a study comparing outcomes in severe asthma patients who start biologic therapies to those who do not.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Status: COMPLETED